Sanofi

🇫🇷France

Country: 🇫🇷France

Ownership: Public

Employees: 87.9K

Market Cap: $141.3B

Website: http://www.sanofi.com

Introduction: Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Clinical Trials

Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance

Phase 4

Completed

Conditions: Malaria

First Posted Date: 2007-03-09

Last Posted Date: 2008-04-10

Lead Sponsor: Sanofi

Target Recruit Count: 300

Registration Number: NCT00445796

Locations: 🇸🇳
Sanofi-Aventis, Dakar, Senegal

Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing

Phase 4

Completed

Conditions: Hypertension

Interventions: Drug: Irbesartan/Hydrochlorothiazide
Drug: Irbesartan

First Posted Date: 2007-03-06

Last Posted Date: 2009-10-01

Lead Sponsor: Sanofi

Target Recruit Count: 60

Registration Number: NCT00443612

Locations: 🇨🇳
Sanofi-Aventis, Taipei, Taiwan

Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease

Phase 2

Completed

Conditions: Intermittent Claudication

Interventions: Drug: placebo
Drug: ataciguat (HMR1766)
Drug: cilostazol

First Posted Date: 2007-03-05

Last Posted Date: 2018-05-17

Lead Sponsor: Sanofi

Target Recruit Count: 553

Registration Number: NCT00443287

Locations: 🇿🇦
Sanofi-Aventis Administrative Office, Midrand, South Africa

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

Phase 2

Completed

Conditions: Japanese Encephalitis

Interventions: Biological: ChimeriVax™-JE
Biological: Japanese Encephalitis Inactivated Mouse Brain Vaccine

First Posted Date: 2007-02-28

Last Posted Date: 2012-08-27

Lead Sponsor: Sanofi

Target Recruit Count: 96

Registration Number: NCT00441259

Locations: 🇮🇳
Maulana Azad Medical College, New Delhi, India
🇮🇳
Government Medical College, Baroda, India
🇮🇳
Dr Atul's Child Hospital, Jaipur, Rajasthan, India